Search Results - "Cyrus Khandanpour"
-
1
From cytopenia to leukemia: the role of Gfi1 and Gfi1b in blood formation
Published in Blood (10-12-2015)“…The DNA-binding zinc finger transcription factors Gfi1 and Gfi1b were discovered more than 20 years ago and are recognized today as major regulators of both…”
Get full text
Journal Article -
2
Editorial: New emerging functions of transcription factors and RNA-binding proteins in the development of hematological malignancies
Published in Frontiers in oncology (01-08-2023)Get full text
Journal Article -
3
Role of GFI1 in Epigenetic Regulation of MDS and AML Pathogenesis: Mechanisms and Therapeutic Implications
Published in Frontiers in oncology (27-08-2019)“…Growth factor independence 1 (GFI1) is a DNA binding zinc finger protein, which can mediate transcriptional repression mainly by recruiting histone-modifying…”
Get full text
Journal Article -
4
The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape
Published in Nature immunology (01-06-2021)“…Progression and persistence of malignancies are influenced by the local tumor microenvironment, and future eradication of currently incurable tumors will, in…”
Get full text
Journal Article -
5
Growth factor independence 1 (Gfi1) as a regulator of lymphocyte development and activation
Published in Seminars in immunology (01-10-2011)“…Highlights ► Gfi1 is required for T-cell development. ► Gfi1 is required for B-cell development and restricts Immunoglobulin production. ► Gfi1 promotes Th2…”
Get full text
Journal Article -
6
The RNA helicase DDX3 and its role in c-MYC driven germinal center-derived B-cell lymphoma
Published in Frontiers in oncology (24-03-2023)“…DDX3X is an RNA helicase with many functions in RNA metabolism such as mRNA translation, alternative pre-mRNA splicing and mRNA stability, but also plays a…”
Get full text
Journal Article -
7
LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML
Published in Leukemia (01-06-2019)“…LSD1 has emerged as a promising epigenetic target in the treatment of acute myeloid leukemia (AML). We used two murine AML models based on retroviral…”
Get full text
Journal Article -
8
Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner
Published in Haematologica (Roma) (01-10-2016)“…The growth of malignant cells is not only driven by cell-intrinsic factors, but also by the surrounding stroma. Monocytes/Macrophages play an important role in…”
Get full text
Journal Article -
9
GFI1 facilitates efficient DNA repair by regulating PRMT1 dependent methylation of MRE11 and 53BP1
Published in Nature communications (12-04-2018)“…GFI1 is a transcriptional regulator expressed in lymphoid cells, and an “oncorequisite” factor required for development and maintenance of T-lymphoid leukemia…”
Get full text
Journal Article -
10
-
11
Transcriptome Profiling Associated with CARD11 Overexpression in Colorectal Cancer Implicates a Potential Role for Tumor Immune Microenvironment and Cancer Pathways Modulation via NF-κB
Published in International journal of molecular sciences (01-10-2024)“…The immune system plays a critical role in inflammation by initiating responses to infections or tissue damage. The nuclear factor-κB (NF-κB) pathway plays a…”
Get full text
Journal Article -
12
A Dominant-Negative GFI1B Mutation in the Gray Platelet Syndrome
Published in The New England journal of medicine (16-01-2014)“…A large family is described with gray platelet syndrome due to an autosomal dominant inheritance pattern related to a dominant-negative mutation in GFI1B . The…”
Get full text
Journal Article -
13
Origin of the brush cell lineage in the mouse intestinal epithelium
Published in Developmental biology (15-02-2012)“…Mix progenitors are short-lived multipotential cells formed as intestinal epithelial stem cells initiate a differentiation program. Clone dynamics indicates…”
Get full text
Journal Article -
14
Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies
Published in Frontiers in oncology (28-08-2019)“…Structural variants (SV) are changes in the genomic landscape that can alter gene expression levels and thus lead to disease development. The most common and…”
Get full text
Journal Article -
15
Effectiveness of high efficiency particulate (HEPA) air condition combined with the antifungal prophylaxis on incidence, morbidity and mortality of invasive fungal infections in patients with acute myeloid leukemia: a retrospective single-center study
Published in Frontiers in oncology (17-10-2024)“…Our monocentric and retrospective study aimed to investigate the clinical effectivity of HEPA filters in combination with the antifungal drug prophylaxis in…”
Get full text
Journal Article -
16
Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS)
Published in International journal of molecular sciences (30-12-2021)“…Growth Factor Independence 1 (GFI1) is a transcription factor with an important role in the regulation of development of myeloid and lymphoid cell lineages and…”
Get full text
Journal Article -
17
Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma
Published in Annals of hematology (01-08-2020)“…Despite significant progress made in the treatment of patients with multiple myeloma (MM) in the last decade, for patients with early relapse or rapidly…”
Get full text
Journal Article -
18
Case report: Tenosynovial giant cell tumor
Published in Frontiers in oncology (26-09-2024)“…Tenosynovial giant cell tumor (TGCT) is a rare type of tumor that originates from the synovium of joints and tendon sheaths. It is characterized by recurring…”
Get full text
Journal Article -
19
Threshold Levels of Gfi1 Maintain E2A Activity for B Cell Commitment via Repression of Id1
Published in PloS one (28-07-2016)“…A regulatory circuit that controls myeloid versus B lymphoid cell fate in hematopoietic progenitors has been proposed, in which a network of the transcription…”
Get full text
Journal Article -
20
Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma
Published in Frontiers in immunology (31-07-2023)“…BackgroundDespite recent advances in the treatment of aggressive lymphomas, a significant fraction of patients still succumbs to their disease. Thus, novel…”
Get full text
Journal Article